Key result
Positive FFR is linked to lower adenosine A2A receptor expression and EC50 levels.
Why the study?
There is a need to develop biomarkers to distinguish among LE-PAD patients those who have associated coronary artery disease.
Does measuring the pharmacological profile of adenosine A2A receptors on PBMCs detect obstructive CAD in patients with LE-PAD?
Cross-Sectional (n=127)
Does measuring the pharmacological profile of adenosine A2A receptors on PBMCs detect obstructive CAD in patients with LE-PAD?
Answers are grounded in this paper and cite their sources.
Measuring the A2A adenosine receptor profile on PBMCs may serve as a useful biomarker to detect associated obstructive CAD in patients with lower extremity peripheral artery disease.
LE-PAD is often associated with coronary artery disease (CAD). There is a need to develop biomarkers to distinguish among LE-PAD those who have associated CAD. The pharmacological profile of adenosine A 2A receptors (expression and cAMP production, EC 50 ) evaluated on PBMCs is useful because these parameters are modified during myocardial ischemia. 127 patients were included. 75 CAD had positive flow-fraction-reserve (FFR) but without intermittent claudication. Among LE-PAD, 27 were with positive-FFR and 25 with negative. A 2A R expression and EC 50 were lower in patients with positive-FFR compared with those with negative. Obstructive CAD might be detected by measuring A 2A adenosine receptors profile.
No takes yet. Share an insight, caveat, or question.
Deharo et al. (2025) conducted a cross-sectional in Lower extremity peripheral artery disease (LE-PAD) and coronary artery disease (CAD) (n=127). Adenosine A2A receptor profile (expression and EC50) vs. Negative FFR was evaluated on A2A receptor expression and EC50. Adenosine A2A receptor expression and EC50 were lower in patients with positive FFR compared to those with negative FFR.
Synapse has enriched 10 related papers. Consider them for comparative context: